Feasibility of a Comprehensive Targeted Cholera Intervention in The Kathmandu Valley, Nepal

A comprehensive targeted intervention (CTI) was designed and deployed in the neighborhoods of cholera cases in the Kathmandu Valley with the intent of reducing rates among the neighbors of the case. This was a feasibility study to determine whether clinical centers, laboratories, and field teams wer...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of tropical medicine and hygiene Vol. 100; no. 5; pp. 1088 - 1097
Main Authors Roskosky, Mellisa, Acharya, Bhim, Shakya, Geeta, Karki, Kshitij, Sekine, Kazutaka, Bajracharya, Deepak, von Seidlein, Lorenz, Devaux, Isabelle, Lopez, Anna Lena, Deen, Jacqueline, Sack, David A
Format Journal Article
LanguageEnglish
Published United States Institute of Tropical Medicine 01.05.2019
The American Society of Tropical Medicine and Hygiene
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A comprehensive targeted intervention (CTI) was designed and deployed in the neighborhoods of cholera cases in the Kathmandu Valley with the intent of reducing rates among the neighbors of the case. This was a feasibility study to determine whether clinical centers, laboratories, and field teams were able to mount a rapid, community-based response to a case within 2 days of hospital admission. Daily line listings were requested from 15 participating hospitals during the monsoon season, and a single case initiated the CTI. A standard case definition was used: acute watery diarrhea, with or without vomiting, in a patient aged 1 year or older. Rapid diagnostic tests and bacterial culture were used for confirmation. The strategy included household investigation of cases; water testing; water, sanitation, and hygiene (WASH) intervention; and health education. A CTI coverage survey was conducted 8 months postintervention. From June to December of 2016, 169 cases of O1 were confirmed by bacterial culture. Average time to culture result was 3 days. On average, the CTI Rapid Response Team (RRT) was able to visit households 1.7 days after the culture result was received from the hospital (3.9 days from hospital admission). Coverage of WASH and health behavior messaging campaigns were 30.2% in the target areas. Recipients of the intervention were more likely to have knowledge of cholera symptoms, treatment, and prevention than non-recipients. Although the RRT were able to investigate cases at the household within 2 days of a positive culture result, the study identified several constraints that limited a truly rapid response.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Authors’ addresses: Mellisa Roskosky, Isabelle Devaux, and David A. Sack, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, E-mails: mroskosky@jhu.edu, idevaux11@gmail.com, and dsack1@jhu.edu. Bhim Acharya, Epidemiology Disease Control Division, Department of Health Services, Kathmandu, Nepal, E-mail: drbacharya@hotmail.com. Geeta Shakya, National Public Health Laboratory, Department of Health Services, Kathmandu, Nepal, E-mail: geeta.nphl@gmail.com. Kshitij Karki and Deepak Bajracharya, Group for Technical Assistance, Kathmandu, Nepal, E-mails: k49karki@gmail.com and bajra.deepak@gmail.com.Kazutaka Sekine, UNICEF Sierra Leone, Freetown, Sierra Leone, E-mail: kazutaka_sekine@hotmail.com. Lorenz von Seidlein, Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom, E-mail: lorenz@tropmedres.ac. Anna Lena Lopez and Jacqueline Deen, Institute of Child Health and Human Development, National Institutes of Health, University of the Philippines, Manila, Philippines, E-mails: annalenalopez@gmail.com and deen.jacqueline@gmail.com.
Financial support: Financial support for data collection, analysis, and preparation of the manuscript was provided by the Delivering Oral Vaccine Effectively (DOVE) project supported by the Bill & Melinda Gates Foundation (OPP1053556 and OPP1148763) administered through the Johns Hopkins Bloomberg School of Public Health.
ISSN:0002-9637
1476-1645
DOI:10.4269/ajtmh.18-0863